Active surveillance in prostate cancer ? a save option when knowing postoperative staging and grading - A single institution experience from 2003-2009

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F09%3A00009661" target="_blank" >RIV/61989592:15110/09:00009661 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Active surveillance in prostate cancer ? a save option when knowing postoperative staging and grading - A single institution experience from 2003-2009
Original language description
Introduction and Objectives: Active surveillance (AS) is a very promising approach to prostate cancer treatment which is based on understanding to biologic behaviour of prostate cancer. Criterions for AS are very well known ? staging <=T2, Gleason score<=3+3a PSA <=10 ng/ml. Aim of our study was to reveal the risk of presence of aggressive prostate cancer on the strenght of available data from bioptic and postprostetectomy staging and grading when indicating active surveillance. Material and Methods: During January 2003 to June 2009 we gathered clinical data from 560 consecutive patients who underwent radical prostatectomy. We evaluated preoperative PSA, bioptic and postoperative Gleason score and clinical and pathological staging. All the specimens were assessed by experienced pathologist from our Teaching Hospital to minimize interindividual variability of evaluating. Results: Preoperative conditions for enrolling the patients to active surveillance, i.e. staging <=T2, G
Czech name
—
Czech description
—

Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)